Linden Advisors’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Linden Advisors’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-500,000	Closed	-$34.9K	–	381
2023 Q3	$34.9K	Hold	500,000	–	–	﹤0.01%	274
2023 Q2	$68.3K	Hold	500,000	–	–	﹤0.01%	256
2023 Q1	$42.9K	Hold	500,000	–	–	﹤0.01%	327
2022 Q4	$23K	Hold	500,000	–	–	﹤0.01%	451
2022 Q3	$72K	Hold	500,000	–	–	﹤0.01%	499
2022 Q2	$55K	Hold	500,000	–	–	﹤0.01%	562
2022 Q1	$112K	Buy	+500,000	New	+$130K	﹤0.01%	577

Linden Advisors's BIOSW Position: Q4 2023 in Review

Linden Advisors sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 500,000 shares — an estimated $34.9K sold.

Linden Advisors first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $112K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Linden Advisors reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Linden Advisors sold 500,000 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $34.9K.
Linden Advisors first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
Linden Advisors's BioPlus Acquisition Corp. Warrants position peaked at $112K in Q1 2022.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Linden Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.